Is Charles River Laboratories International, Inc. overvalued?

Charles River Laboratories International, Inc. (CRL) looks overvalued — trading about 26% above its fair value.

Overvalued

Price

$337.97

Fair value

$248.57

Current P/E

33.8

Normal P/E

24.9

Market cap

$16.19B

Dividend yield

0.0%

Return on equity

1.3%

Sector

Healthcare

Fair value compares CRL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks